Abstract
Shaw C, Starling N, Reich A, et al. Modification of systemic anti-cancer therapies and weight loss, a population-level real-world evidence study. Ther Adv Med Oncol 2020; 12:1–64. DOI: 10.1177/1758835920982805
While preparing this paper, the OR for stomach cancer was incorrectly listed in the “Results” section of the abstract. The correct value is as given below:
Binary weight loss was associated (p<0.05) with higher likelihood of treatment modification in; colon [Odds Ratio (OR)=1.72, 95% confidence interval (CI): 1.42, 2.07]; gynaecologic (excl. ovarian) (OR=1.48, 95% CI: 1.08, 2.01); stomach (OR=1.46, 95% CI: 1.04, 2.06); lung (OR=1.38, 95% CI: 1.21, 1.58); leukaemia (OR=1.30, 95% CI: 1.09, 1.55); head and neck (OR=1.30, 95% CI: 1.02, 1.65) and oesophageal (OR=1.29, 95% CI: 1.01, 1.64) cancers.
The online version of the paper has now been corrected.